Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: A comparative study

Định dạng: PDF / Số trang: 8

Nhắn tin với admin nếu không tải được